HEAL-SLE: Holistic Energy for Alleviating Lupus Symptoms
NCT07203157 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2025-10-02
Summary
The purpose of this study is to assess the efficacy, feasibility, and acceptability of Virtual Reiki therapy as a complementary treatment for patients with systemic lupus erythematosus (SLE). The study also aims to investigate the feasibility, acceptability, and adherence of integrating Virtual Reiki therapy within the healthcare system for patients with SLE. Participants receiving standard of care (SOC) treatment for SLE will continue SOC while receiving research-specific Virtual Reiki therapy once per week for 8 weeks. Each study session will be delivered remotely by a Certified Reiki Practitioner Level II or higher.
Conditions
Interventions
- OTHER
-
Virtual Reiki Therapy
20-minute session once per week for 8 weeks via Webex. Each session will be delivered remotely by a Certified Reiki Practitioner Level II or higher.
Sponsors & Collaborators
-
Daisy Foundation
collaborator OTHER - lead OTHER
Principal Investigators
-
Monica Gamez-Perez, RN, BSN · NYU Langone Health
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-15
- Primary Completion
- 2026-03-31
- Completion
- 2026-09-20
Countries
- United States
Study Locations
More Related Trials
-
Photoprovocation Testing in Subjects With Cutaneous Lupus
NCT01516788 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Intense Pulsed Light in the Treatment of Facial Telangiectasia in Systemic Lupus Erythematosus
NCT04717583 ·Status: UNKNOWN ·Phase: NA
-
Vitamin D Supplementation in Systemic Lupus Erythematosus
NCT01413230 ·Status: COMPLETED
-
Low-dose IL-2( Interleukin-2) Treatment in SLE
NCT02084238 ·Status: COMPLETED ·Phase: NA
-
Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord
NCT03562065 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE)
NCT05426902 ·Status: COMPLETED ·Phase: NA
-
Research Accelerated by You Lupus Registry
NCT06927219 ·Status: RECRUITING
-
Water-based Liuzijue Exercise on Childhood-onset Systemic Lupus Erythematosus
NCT07024082 ·Status: COMPLETED ·Phase: NA
-
Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients
NCT04032496 ·Status: UNKNOWN ·Phase: NA
-
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus
NCT06032923 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Psychoeducational Approach to Improve Health in Lupus
NCT00000417 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial
NCT04077684 ·Status: COMPLETED ·Phase: PHASE2
-
Mindfulness- Based Intervention for Systemic Lupus Erythematosus (SLE) Patients
NCT04305418 ·Status: COMPLETED ·Phase: NA
-
Cutaneous Lupus Registry
NCT01266915 ·Status: RECRUITING
-
The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy.
NCT05132621 ·Status: UNKNOWN
-
Whole Health Empowerment for Endotypes of Lupus: Improving Quality of Life in SLE
NCT06720584 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus Erythematosus
NCT01629784 ·Status: COMPLETED ·Phase: NA
-
Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion
NCT01551069 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus
NCT02465580 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE)
NCT02660944 ·Status: COMPLETED ·Phase: PHASE2
-
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study
NCT00342095 ·Status: COMPLETED
-
Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain
NCT02822989 ·Status: UNKNOWN ·Phase: NA
-
Systemic Lupus Erythematosus in Gullah Health
NCT00756769 ·Status: RECRUITING
-
Safety and Efficacy of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE)
NCT06458972 ·Status: RECRUITING
-
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus
NCT01405196 ·Status: COMPLETED ·Phase: PHASE2